Kalbe Farma Tbk PT (KLBF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kalbe Farma Tbk PT (KLBF) has a cash flow conversion efficiency ratio of 0.041x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp1.05 Trillion ≈ $61.81 Million USD) by net assets (Rp25.76 Trillion ≈ $1.51 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Kalbe Farma Tbk PT (KLBF) market capitalisation for the company's overall valuation and market capitalisation.
Kalbe Farma Tbk PT - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Kalbe Farma Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Kalbe Farma Tbk PT Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kalbe Farma Tbk PT ranked by their cash flow conversion efficiency. Explore Kalbe Farma Tbk PT (KLBF) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Beijing United Information Technology Co Ltd
SHG:603613
|
-0.011x |
|
DANAOS CORP. DL -01
F:DVW1
|
0.047x |
|
Buckle Inc
NYSE:BKE
|
0.107x |
|
Ningbo Huaxiang Electronic Co Ltd
SHE:002048
|
0.037x |
|
Scandic Hotels Group AB (publ)
ST:SHOT
|
0.696x |
|
The Bancorp Inc
NASDAQ:TBBK
|
0.049x |
|
UroGen Pharma Ltd
NASDAQ:URGN
|
0.249x |
|
Ratnamani Metals & Tubes Limited
NSE:RATNAMANI
|
0.176x |
Annual Cash Flow Conversion Efficiency for Kalbe Farma Tbk PT (2000–2025)
The table below shows the annual cash flow conversion efficiency of Kalbe Farma Tbk PT from 2000 to 2025. View latest Kalbe Farma Tbk PT stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Rp24.73 Trillion ≈ $1.45 Billion |
Rp3.27 Trillion ≈ $191.65 Million |
0.132x | -32.03% |
| 2024-12-31 | Rp24.59 Trillion ≈ $1.44 Billion |
Rp4.79 Trillion ≈ $280.39 Million |
0.195x | +54.74% |
| 2023-12-31 | Rp23.12 Trillion ≈ $1.35 Billion |
Rp2.91 Trillion ≈ $170.37 Million |
0.126x | -26.28% |
| 2022-12-31 | Rp22.10 Trillion ≈ $1.29 Billion |
Rp3.77 Trillion ≈ $220.87 Million |
0.171x | +28.37% |
| 2021-12-31 | Rp21.27 Trillion ≈ $1.25 Billion |
Rp2.83 Trillion ≈ $165.59 Million |
0.133x | -42.38% |
| 2020-12-31 | Rp18.28 Trillion ≈ $1.07 Billion |
Rp4.21 Trillion ≈ $246.97 Million |
0.231x | +53.92% |
| 2019-12-31 | Rp16.71 Trillion ≈ $978.88 Million |
Rp2.50 Trillion ≈ $146.66 Million |
0.150x | -17.30% |
| 2018-12-31 | Rp15.29 Trillion ≈ $896.20 Million |
Rp2.77 Trillion ≈ $162.36 Million |
0.181x | +25.33% |
| 2017-12-31 | Rp13.89 Trillion ≈ $814.14 Million |
Rp2.01 Trillion ≈ $117.68 Million |
0.145x | -16.59% |
| 2016-12-31 | Rp12.46 Trillion ≈ $730.33 Million |
Rp2.16 Trillion ≈ $126.56 Million |
0.173x | -22.85% |
| 2015-12-31 | Rp10.94 Trillion ≈ $640.94 Million |
Rp2.46 Trillion ≈ $143.97 Million |
0.225x | -4.79% |
| 2014-12-31 | Rp9.82 Trillion ≈ $575.27 Million |
Rp2.32 Trillion ≈ $135.72 Million |
0.236x | +116.28% |
| 2013-12-31 | Rp8.50 Trillion ≈ $498.06 Million |
Rp927.16 Billion ≈ $54.33 Million |
0.109x | -41.58% |
| 2012-12-31 | Rp7.37 Trillion ≈ $431.95 Million |
Rp1.38 Trillion ≈ $80.65 Million |
0.187x | -17.44% |
| 2011-12-31 | Rp6.52 Trillion ≈ $381.81 Million |
Rp1.47 Trillion ≈ $86.34 Million |
0.226x | +13.15% |
| 2010-12-31 | Rp5.77 Trillion ≈ $338.21 Million |
Rp1.15 Trillion ≈ $67.60 Million |
0.200x | -29.78% |
| 2009-12-31 | Rp4.79 Trillion ≈ $280.71 Million |
Rp1.36 Trillion ≈ $79.90 Million |
0.285x | +53.10% |
| 2008-12-31 | Rp4.34 Trillion ≈ $254.57 Million |
Rp807.70 Billion ≈ $47.33 Million |
0.186x | +105.77% |
| 2007-12-31 | Rp4.02 Trillion ≈ $235.36 Million |
Rp362.90 Billion ≈ $21.26 Million |
0.090x | -50.02% |
| 2006-12-31 | Rp3.54 Trillion ≈ $207.67 Million |
Rp640.61 Billion ≈ $37.54 Million |
0.181x | +15.14% |
| 2005-12-31 | Rp2.81 Trillion ≈ $164.74 Million |
Rp441.37 Billion ≈ $25.86 Million |
0.157x | -45.36% |
| 2004-12-31 | Rp1.48 Trillion ≈ $86.69 Million |
Rp425.07 Billion ≈ $24.91 Million |
0.287x | -42.02% |
| 2003-12-31 | Rp1.02 Trillion ≈ $59.97 Million |
Rp507.17 Billion ≈ $29.72 Million |
0.496x | -19.13% |
| 2002-12-31 | Rp651.41 Billion ≈ $38.17 Million |
Rp399.13 Billion ≈ $23.39 Million |
0.613x | +25.47% |
| 2001-12-31 | Rp345.97 Billion ≈ $20.27 Million |
Rp168.95 Billion ≈ $9.90 Million |
0.488x | +52.08% |
| 2000-12-31 | Rp305.74 Billion ≈ $17.91 Million |
Rp98.17 Billion ≈ $5.75 Million |
0.321x | -- |
About Kalbe Farma Tbk PT
PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devi… Read more